Trailblazers win international peptide symposium
Two Brisbane scientists blazing a trail in the emerging field of peptide research have helped secure a key symposium that will attract researchers from across the globe to the city.
Set to take place in Brisbane for the first time in 2021, the five-day International Peptide Symposium is expected to attract more than 600 delegates from the United Kingdom, Europe, America, Asia and Australia.
The scientists, Dr Christina Schroeder and Dr Johan Rosengren from the University of Queensland, worked in collaboration with the team at the Brisbane Convention & Exhibition Centre, Brisbane Economic Development Agency and Tourism & Events Queensland on the successful symposium bid.
As featured in our previous Business Events e-News, the pair are on the Executive Committee of the Australian Peptide Symposium and were recipients of the Brisbane Lord Mayor’s Convention Trailblazer Grant in 2018.
Brisbane EDA launched the Lord Mayor’s Convention Trailblazer Grant in 2018 as an initiative designed to empower the city’s early-career professionals and researchers to make their mark and to grow Brisbane’s reputation as a global conventions city.
Dr Schroeder and Dr Rosengren attended at the 2018 International Symposium in Kyoto to highlight Brisbane’s expertise in the field and help secure the event for Brisbane.
Peptides are a key area of research growth in Australia, particularly with advances in research in drug design and agricultural applications, with the University of Queensland leading the way.
Dr Rosengren said the Symposium will cover a broad range of topics in peptide science, attracting the world’s leading researchers and scientists in the field.
“The field of peptide science has rapidly matured in Australia with the sector outstripping other types of drug research, with scientists in Brisbane leading the way, focussing on the areas of bio pesticides and drug design,” he said.
“This event is a unique opportunity to showcase local research and provide a global platform for the exchange of science and knowledge and the opportunity for research growth and investment in the sector.”
Dr Schroeder said she was inspired to get into the industry because it delivers high impact medical research.
“I am inspired by the life-changing benefits which bioactive venom peptide research aims to achieve and excited about the current research in our industry and the development of novel, potent therapies with fewer side effects,” she said.
“Bringing the symposium to Brisbane will further cement Australia’s role as a key player in the global peptide community – the conference will bring delegates from all over the world to the city. The symposium will also give the Australian Peptide Association an opportunity to strengthen its international reputation.”
Dr Rosengren said the support from Brisbane EDA and the Brisbane Convention & Exhibition Centre was crucial to winning the bid.
“The team assisted us with applying for conference funding and made the whole process easy thanks to their support every step of the way,” he said.
“Collaborations are essential for success in research and hosting the symposium in Brisbane will help further strengthen and grow our international knowledge network.
“It will be an exciting opportunity for the University of Queensland to showcase its world class research, and for the large number of peptide scientists at UQ and other universities across Brisbane and Queensland to interact with leading scientists from around the world.”
Read the full announcement here.